Weight Loss Guide, The Care Pharmacy
Menopause changes how and where your body stores weight. Here is how GLP-1 medicines fit into that picture, who tends to be eligible, and how the main options compare.
Weight gain during perimenopause and menopause is one of the most common complaints raised in GP surgeries, and one of the most frustrating for the women experiencing it. Diet and exercise habits that used to keep weight steady often stop working in quite the same way, and the weight that does creep on tends to settle around the middle rather than spreading evenly. It is no surprise, then, that interest in prescription weight loss medicines, injections and tablets alike, has grown sharply among women in this stage of life. This guide looks at why menopause affects weight the way it does, whether these medicines are genuinely suitable for menopausal weight gain, and how the different options on the market compare.
If you think a prescription treatment might be worth exploring, get in touch with our team with any questions, or complete our online consultation to find out which option, if any, is appropriate for you.
Quick Answer
On this page
Weight gain around menopause is not simply a matter of willpower slipping. There are genuine physiological changes at play, and understanding them helps explain why some women find that what used to work for their weight suddenly does not.
None of this means weight gain during menopause is inevitable or unmanageable, but it does explain why the same diet and exercise routine that worked in your thirties may need to be adapted, and why some women look towards medical support as part of a wider plan.
Most of the prescription weight loss medicines available in the UK today belong to a class called GLP-1 receptor agonists. GLP-1 is a hormone your body naturally produces after eating, and it plays a role in signalling fullness to the brain. Medicines in this class mimic that hormone, which:
Not every weight loss medicine works this way, however. Orlistat, for example, takes a completely different approach, acting in the gut to reduce the amount of dietary fat that is absorbed, rather than affecting appetite at all. Because these mechanisms differ so much, the right choice depends on personal preference, tolerance and clinical suitability, not just on which medicine is newest or most talked about.
It is worth being clear about something that often gets blurred in online discussion: menopause itself is not a licensed qualifying condition for weight loss medication. Eligibility for these treatments in the UK is based on the same criteria regardless of the reason someone is carrying extra weight, generally:
This does not mean menopause is irrelevant to the conversation. A prescriber will still want to know about your menopausal status, any hormone replacement therapy (HRT) you are taking, and other symptoms you are experiencing, because these all form part of a complete clinical picture. But the formal eligibility criteria are based on BMI and associated health conditions, not on menopausal status alone.
If you are on HRT or considering starting it, mention this clearly during any consultation. It is not generally a barrier to being prescribed a weight loss medicine, but a prescriber needs the full picture of what you are taking before making a recommendation.
There is more choice available now than there was even a couple of years ago, spanning weekly injections, daily injections, daily tablets, and non-GLP-1 medicines. Here is an overview of what is currently available.
Mounjaro is a once-weekly injection and a dual-acting GLP-1 and GIP receptor agonist, which is part of why it has become one of the most widely discussed options. It is licensed for weight management and for improving blood sugar control in type 2 diabetes.
Also a once-weekly injection, Wegovy is one of the most established GLP-1 medicines for weight management in the UK, with a substantial body of real-world use behind it.
Nevolat is a daily-dose injectable option, which suits patients who prefer a smaller, more frequent dose over a single larger weekly injection, or whose prescriber recommends a daily dosing pattern for their circumstances.
A well-established daily injection, licensed for weight management, that was widely used in the UK before the newer weekly options became available. Some patients prefer the daily routine of Saxenda, and longer track record.
This is an oral tablet version within the same medicine family as injectable Wegovy, aimed at patients who want the option of GLP-1 based treatment without using a needle at all.
A once-daily tablet, Foundayo or orforglipron was authorised by the MHRA in August 2026, offering a needle-free GLP-1 option with no fasting or specific water requirements around dosing.
A capsule taken with meals that works in a completely different way to GLP-1 medicines, reducing the amount of dietary fat absorbed in the gut rather than acting on appetite. It suits patients who prefer a non-hormonal approach, or whose clinical circumstances make a GLP-1 medicine less suitable.
A prescriber will help you weigh these up against your own preferences, whether that is avoiding needles, wanting the least frequent dosing schedule, or wanting an option with a longer safety track record.
Medication is only one part of managing menopausal weight gain, and it works best when combined with a few specific lifestyle adjustments that matter more during this stage of life than at others:
None of this is about being told to simply try harder. It is about recognising that the strategies which worked before menopause may need updating to reflect what is happening in your body now, and that medication, where appropriate, is a support for these changes rather than a replacement for them.
Many women do use HRT and a weight loss medicine at the same time, but this needs to be reviewed individually by a prescriber who knows your full medical history. Always disclose any HRT, or any other medicine you are taking, during your consultation so this can be properly assessed.
The underlying mechanism of these medicines does not change based on menopausal status, but individual results always vary depending on factors including hormone levels, muscle mass, activity levels and overall health. This is exactly why an individual assessment matters more than a general expectation of results.
This largely comes down to personal preference. Tablets such as Foundayo or the Wegovy pill avoid needles entirely, while injections such as Mounjaro or Wegovy involve a weekly routine that some patients find easier to remember than a daily dose. A prescriber can talk through which fits your lifestyle best.
Orlistat is a genuinely different option, working by reducing fat absorption rather than affecting appetite, so it can suit patients who prefer to avoid hormone-based medicines or who have not tolerated GLP-1 options well. Whether it is the right choice still depends on your individual health profile and goals.
GLP-1 based medicines commonly cause nausea, vomiting, diarrhoea and reduced appetite, particularly during dose increases, while Orlistat’s side effects are mainly digestive and related to fat intake. Your prescriber will talk you through what to expect for your specific treatment and what warrants contacting them.
Weight gain during menopause has real physiological causes, and it is entirely reasonable to look at medical options alongside lifestyle changes if diet and exercise alone are not giving you the results you would expect. What matters is choosing based on accurate information rather than assuming menopause itself unlocks eligibility, and picking the specific medicine that suits your preferences and health profile rather than whichever one is most talked about.
Get in touch with our team if you have questions about any of these options, or complete our online consultation to find out which treatment, if any, is right for you.
Ready to explore your options?
Start a free, confidential online consultation with our pharmacist-led team to find the weight loss treatment that fits your circumstances.
This article was clinically reviewed by our Superintendent Pharmacist, who is registered with the General Pharmaceutical Council and leads clinical governance across The Care Pharmacy’s weight management services.
Last reviewed: September 2026
Disclaimer: This article is for general information only and is not a substitute for individual medical advice. Always consult a qualified prescriber before starting any prescription weight loss treatment.
Medically reviewed by
Superintendent Pharmacist
Weight Loss Guide, The Care Pharmacy LillyDirect in the UK: What Weight Loss Patients Really Need to Know A clear, UK-specific breakdown of what LillyDirect actually is, how it differs from the American version, and the safe, regulated way to access Mounjaro for weight management. Explore Weight Loss Treatment at The Care Pharmacy A […]
June 2026 · The Care Pharmacy · Clinically reviewed by Mohammed Ismail Lakhi MPharm, Superintendent Pharmacist The question coming up more and more: is there a pill version of Mounjaro or Wegovy? The short answer is – the Wegovy pill is available now in the UK. The landscape has moved fast, and understanding what’s available […]
Thinking of switching your weight loss treatment to The Care Pharmacy? Moving providers doesn’t mean restarting. This guide covers how switching works, what happens to your dose, what to bring, First Dose Video Supervision, transparent pricing for Mounjaro, Wegovy and Saxenda, and how to compare providers safely before you make the move.
If you have been searching for Wegovy in the UK, you are not alone. Demand for semaglutide has grown significantly since its MHRA approval, and patients are increasingly asking where they can access it, how quickly, and at what cost. The short answer is that access has improved considerably in 2026 — but the route […]
If you are considering starting a weight loss medication, or you have already begun treatment and want to know what to expect, one of the most common questions is: How much weight can you lose in a month? The answer is not a single number. It depends on the medication, your starting weight, your lifestyle, […]
Mounjaro Price Comparison UK Guide · Updated March 2026 The same pen. The same manufacturer. Up to £100/month difference in price depending on where you buy it. This is the most comprehensive Mounjaro price comparison UK guide available — every dose, every hidden cost, NHS vs private access, and how to buy safely from a […]
